These findings suggest that this cannabinoid derivative is an immunomodulator that could be developed as a potential drug for hepatitis as well as for other short- or long-term inflammatory diseases.
Link: A novel synthetic cannabinoid derivative inhibits inflammatory liver damage via negative cytokine regulation.
Year: 2003
Possible to probable range of efficacy of cannabis for treatment of Hepatitis according to the results found in this study.
PRS-211,092